Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 60760-810

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 60760-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\ra\2011 Anda\orphenadrine Citrate Er Tablets\cbe (Labeling\Backup\062812\figure-01.jpg)

Chemical structure diagram of Orphenadrine Citrate, showing the molecular arrangement of its components as presented in the product data for Orphenadrine Citrate tablet extended release 100 mg.*

FDA Label Image

Orphenadrine 60760 810 30

Orphenadrine Citrate Extended-Release 100 mg tablets packaging label displaying quantity of 30 tablets. The label lists NDC 60760-810-30 and indicates manufacturing by Novel Laboratories, Inc., Somerset, NJ, and packaging by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Instructions note to use as directed and to store at controlled room temperature 15°-30°C (59°-86°F). Expiration and lot numbers are obscured.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.